gastric mucosal hypertrophy

Descriptive versus diagnostic use

Record whether the term describes enlarged mucosa, reports a pathological conclusion or stands for a specifically diagnosed disease.

1. Does the originating record use gastric mucosal hypertrophy as a morphological observation or a disease diagnosis? definition
2. Which report, author and examination support that interpretation? provenance

Mucosal versus wall thickening

Keep whole-wall thickening, prominent folds and demonstrated mucosal expansion as distinct observations.

1. What evidence localises the enlargement to the mucosa rather than submucosa or muscularis propria? boundary
2. Was the reported dimension mucosal thickness, fold height or total gastric wall thickness? measurement

Involvement and sparing

Record the regional pattern without converting apparent sparing into an unsampled histological conclusion.

1. Which gastric regions show enlarged mucosa, and is involvement focal, patchy or diffuse? measurement
2. Is reported antral sparing based on endoscopic appearance, tissue sampling or both? provenance

Persistent fold enlargement

Document distension, surface appearance and the relationship between enlarged folds and discrete lesions.

1. Do the folds remain enlarged with documented adequate gastric distension? measurement
2. Are the abnormalities continuous rugal folds, discrete polyps or a mixture? boundary
3. Are mucus, erosions, ulceration or contact bleeding recorded at the affected sites? measurement

Epithelial and stromal contributions

Record foveolar and glandular architecture separately from edema, inflammation and abnormal infiltrates. Architectural and inflammatory distinctions have been examined in gastric foveolar lesions. [Histological study](https://pubmed.ncbi.nlm.nih.gov/9368593/)

1. Which compartments are expanded, and are glandular dilation, tortuosity or atrophy documented? measurement
2. Does the specimen demonstrate hyperplasia, individual-cell hypertrophy, edema, infiltration or an unresolved combination? definition

Architectural assessment adequacy

Record specimen depth, orientation and site matching. A diagnostic study of suspected Ménétrier disease emphasised full-thickness mucosal sampling within an integrated evaluation. [Diagnostic cohort](https://pubmed.ncbi.nlm.nih.gov/20926644/)

1. Does the sample preserve the full mucosal architecture needed for the proposed interpretation? measurement
2. Were samples taken from the enlarged folds and labelled by gastric region? provenance
3. Does inadequate or discordant tissue evidence justify clinician consideration of additional sampling or pathology review? action

Gastric protein loss attribution

Record albumin and edema alongside the evidence for gastrointestinal loss and any alternative explanations.

1. What are the dated albumin measurements and documented findings of edema or nutritional decline? measurement
2. What evidence attributes protein depletion to gastric loss rather than another gastrointestinal, renal, hepatic or nutritional process? boundary

Secretory and clinical profile

Capture measured acidity, gastrin where assessed, medication context and the temporal relationship of symptoms to mucosal findings.

1. What gastric pH, acid-output or gastrin results are available, and under what testing and medication conditions? measurement
2. Are pain, vomiting, early satiety, bleeding or weight change temporally associated with the gastric abnormality? measurement
3. Which documented functional consequences require clinician assessment before routine follow-up? action

Ménétrier pattern assessment

Assess the combination of distribution, foveolar architecture, parietal-cell findings and functional evidence; enlarged folds alone are insufficient. [Diagnostic cohort](https://pubmed.ncbi.nlm.nih.gov/20926644/)

1. Which clinical, endoscopic and histological observations support or contradict Ménétrier disease? boundary
2. Has a clinician established a specific gastropathy diagnosis, or does the record remain a descriptive phenotype? provenance

Competing cause evidence

Maintain supporting and conflicting observations for each clinically raised alternative, distinguishing an unperformed test from an adequate negative result.

1. What evidence addresses clinically suspected hypersecretory disease, infection, inflammatory disease, polyposis or neoplasia? boundary
2. For each relevant negative result, were the method, anatomical site and sample adequacy sufficient to address the suspected process? provenance
3. Which unresolved alternative most materially changes the next clinician-led assessment? action

Morphological and functional trajectory

Track fold appearance, tissue findings and functional consequences independently, relating changes to dated interventions without asserting causation.

1. Are repeat observations comparable by gastric site, modality, distension and sampling depth? measurement
2. Have mucosal enlargement, albumin abnormalities and symptoms changed together or diverged? measurement
3. Which interventions or exposures preceded the changes, and what limits causal attribution? provenance

Unresolved lesion follow-up

Tie review to documented findings and any established underlying disease, without assigning a universal surveillance schedule to the phenotype.

1. Are progressive thickening, unexplained bleeding, persistent ulceration or discordant pathology awaiting review? action
2. What clinician-defined follow-up addresses each unresolved gastric finding, and who is responsible? action
3. Does a proposed surveillance schedule derive from an established disease diagnosis or only from this descriptive label? boundary

Check these first

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these check these first hold for the sense of gastric mucosal hypertrophy this model covers, and on what evidence? provenance

Kinds and varieties

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these kinds and varieties hold for the sense of gastric mucosal hypertrophy this model covers, and on what evidence? provenance

Real-world use

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these real-world use hold for the sense of gastric mucosal hypertrophy this model covers, and on what evidence? provenance

Failure modes and hazards

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these failure modes and hazards hold for the sense of gastric mucosal hypertrophy this model covers, and on what evidence? provenance

Neighbouring kinds and how to tell them apart

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these neighbouring kinds and how to tell them apart hold for the sense of gastric mucosal hypertrophy this model covers, and on what evidence? provenance